NeuroDerm CEO to Present at Upcoming Investor Conferences
27 Février 2017 - 10:01PM
NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical
company developing drugs for central nervous system (CNS) diseases,
today announced that CEO Oded S. Lieberman, PhD will present at the
following investor conferences:
- Cowen and Company 37th Annual Health Care Conference taking
place in Boston, Massachusetts from March 6 – 8, 2017. Dr.
Lieberman’s presentation will take place on Monday, March 6 at
2:00pm ET.
- 29th Annual ROTH Conference taking place in Dana Point,
California from March 12 – 15, 2017. Dr. Lieberman’s presentation
will take place on Tuesday, March 14 at 9:00am PT, 12:00pm ET.
To access the live webcast of the presentation,
please visit ir.neuroderm.com/. A replay will be available
for a limited time following the presentation.
About NeuroDermNeuroDerm is a clinical-stage
pharmaceutical company developing central nervous system (CNS)
product candidates that are designed to overcome major deficiencies
of current treatments and achieve enhanced clinical efficacy
through continuous, controlled administration. NeuroDerm is
headquartered in the Rabin Science Park, Rehovot, Israel.
NeuroDerm Contact:Oded S.
Lieberman, PhD, CEOoded@neuroderm.comTel.: +972-8-946 2729; Cell:
+1-617-517 6077
U.S. Investor Contact:David
CareyLazar Partners Ltd.dcarey@lazarpartners.com+212-867-1768
NEURODERM LTD. (NASDAQ:NDRM)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
NEURODERM LTD. (NASDAQ:NDRM)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Neuroderm Ltd. - Ordinary Shares (NASDAQ): 0 recent articles
Plus d'articles sur